FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for nitrofurantoin monohydrate/macrocrystals filed by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis
• Urinary Tract Infection

Drugs mentioned

• Nitrofurantoin (monohydrate/macrocrystals) (Nitrofurantoin monohydrate/macrocystals)

Snippet

SUPPL AP for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS))